Statistics in Biopharmaceutical Research | 2021
A Seamless Adaptive 2-in-1 Design Expanding a Phase 2 Trial for Treatment or Dose Selection Into a Phase 3 Trial
Abstract
Seamless adaptive phase 2-3 designs provide possible pathways to expedite drug developments by allowing the expansion of an ongoing Phase 2 trial into a confirmatory Phase 3 trial. Here we propose ...